HCMZX
Price
$20.83
Change
-$0.09 (-0.43%)
Updated
Sep 20 closing price
RWIFX
Price
$67.87
Change
-$0.15 (-0.22%)
Updated
Sep 20 closing price
Ad is loading...

HCMZX vs RWIFX

Header iconHCMZX vs RWIFX Comparison
Open Charts HCMZX vs RWIFXBanner chart's image
HCM Dividend Sector Plus R
Price$20.83
Change-$0.09 (-0.43%)
VolumeN/A
CapitalizationN/A
American Funds Capital World Gr&Inc R5
Price$67.87
Change-$0.15 (-0.22%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
HCMZX vs RWIFX Comparison Chart
Loading...
VS
HCMZX vs. RWIFX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HCMZX is a StrongBuy and RWIFX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RWIFX has more cash in the bank: 128B vs. HCMZX (1.62B). RWIFX pays higher dividends than HCMZX: RWIFX (1.94) vs HCMZX (0.34). HCMZX was incepted earlier than RWIFX: HCMZX (10 years) vs RWIFX (22 years). HCMZX is a more actively managed with annual turnover of: 178.00 vs. RWIFX (27.00). HCMZX has a lower initial minimum investment than RWIFX: HCMZX (0) vs RWIFX (250). RWIFX annual gain was more profitable for investors over the last year : 20.37 vs. HCMZX (15.40). HCMZX return over 5 years is better than : 84.74 vs. RWIFX (44.74).
HCMZXRWIFXHCMZX / RWIFX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence10 years22 years-
Gain YTD16.46712.691130%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets1.62B128B1%
Annual Yield % from dividends0.341.9418%
Returns for 1 year15.4020.3776%
Returns for 3 years3.126.6547%
Returns for 5 years84.7444.74189%
Returns for 10 yearsN/A49.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALVO11.070.06
+0.54%
Alvotech
BFS40.460.18
+0.45%
Saul Centers
IOT47.55N/A
N/A
Samsara
MBOT0.93-0.01
-1.25%
Microbot Medical
FULC3.44-0.05
-1.43%
Fulcrum Therapeutics